12 Seth Klarman Atara Biotherapeutics Trades
Seth Klarman's position in Atara Biotherapeutics is currently worth $41.9 Million. That's 0.52% of their equity portfolio (25th largest holding). The investor owns 8.7% of the outstanding Atara Biotherapeutics stock. Seth Klarman started to build up the position in Atara Biotherapeutics in Q4 2014 and continued to invest until Q2 2020. Since then they sold 1.8 Million shares. The investor's estimated purchase price is $198 Million, resulting in a loss of 79%.
Avg closing price
Price range
Sold 4.2% shares (-354 Thousand shares)
Q1 2022
Avg closing price
$12.74
Price range
$8.44
-
$16.89
Sold 6.9% shares (-632 Thousand shares)
Q1 2021
Avg closing price
$17.68
Price range
$14.00
-
$20.72
Sold 8.2% shares (-813 Thousand shares)
Q4 2020
Avg closing price
$18.46
Price range
$12.67
-
$26.23
Increased shares by 19.4% (+1.61 Million shares)
Q2 2020
Avg closing price
$10.10
Price range
$7.53
-
$14.93
Increased shares by 18.7% (+1.31 Million shares)
Q3 2019
Avg closing price
$14.92
Price range
$12.03
-
$19.94
Increased shares by 9.7% (+619 Thousand shares)
Q2 2019
Avg closing price
$28.23
Price range
$19.05
-
$41.04
Increased shares by 2.0% (+126 Thousand shares)
Q1 2019
Avg closing price
$37.17
Price range
$28.40
-
$41.74
Increased shares by 16.7% (+895 Thousand shares)
Q1 2018
Avg closing price
$36.45
Price range
$18.00
-
$48.35
Increased shares by 11.4% (+550 Thousand shares)
Q3 2015
Avg closing price
$48.79
Price range
$31.44
-
$63.11
Increased shares by 1.0% (+46.4 Thousand shares)
Q2 2015
Avg closing price
$45.89
Price range
$36.67
-
$64.02
Increased shares by 90.8% (+2.27 Million shares)
Q1 2015
Avg closing price
$26.44
Price range
$18.00
-
$42.90
New holding (+2.5 Million shares)
Q4 2014
Avg closing price
$24.73
Price range
$10.65
-
$31.80
